Research ArticleBasic Science Investigations
A Combined PET/CT Scanner for Clinical Oncology
Thomas Beyer, David W. Townsend, Tony Brun, Paul E. Kinahan, Martin Charron, Raymond Roddy, Jeff Jerin, John Young, Larry Byars and Ronald Nutt
Journal of Nuclear Medicine August 2000, 41 (8) 1369-1379;
Thomas Beyer
David W. Townsend
Tony Brun
Paul E. Kinahan
Martin Charron
Raymond Roddy
Jeff Jerin
John Young
Larry Byars
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
A Combined PET/CT Scanner for Clinical Oncology
Thomas Beyer, David W. Townsend, Tony Brun, Paul E. Kinahan, Martin Charron, Raymond Roddy, Jeff Jerin, John Young, Larry Byars, Ronald Nutt
Journal of Nuclear Medicine Aug 2000, 41 (8) 1369-1379;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Dose Reduction in Pediatric Oncology Patients with Delayed Total-Body [18F]FDG PET/CT
- FAPI PET/CT: Will It End the Hegemony of 18F-FDG in Oncology?
- Establishment of National DRL for CT in Hybrid Imaging Studies (The Second Phase of the National NM CT (PET) Dose Audit for Kuwait Population -2019)
- On the Origin of Hybrid Imaging (perspective on "A Combined PET/CT Scanner for Clinical Oncology" J Nucl Med. 2000;41:1369-1379)
- PET/MRI Versus PET/CT for Whole-Body Staging: Results from a Single-Center Observational Study on 1,003 Sequential Examinations
- Fifty Years of Radiopharmaceuticals
- The Future of Nuclear Medicine as an Independent Specialty
- Driving the Future of Nuclear Medicine
- Radiomics: Data Are Also Images
- Performance Characteristics of the Digital Biograph Vision PET/CT System
- Variations in PET/MRI Operations: Results from an International Survey Among 39 Active Sites
- PET and MRI: Is the Whole Greater than the Sum of Its Parts?
- Evaluation of Prostate Cancer with 11C-Acetate PET/CT
- Dixon Sequence with Superimposed Model-Based Bone Compartment Provides Highly Accurate PET/MR Attenuation Correction of the Brain
- 18F-FDG PET/CT and PET/MRI Perform Equally Well in Cancer: Evidence from Studies on More Than 2,300 Patients
- Diagnostic Reference Levels of CT Radiation Dose in Whole-Body PET/CT
- Whole-Body PET/MR Imaging: Quantitative Evaluation of a Novel Model-Based MR Attenuation Correction Method Including Bone
- Reconstruction-Incorporated Respiratory Motion Correction in Clinical Simultaneous PET/MR Imaging for Oncology Applications
- Combined PET/MR: A Technology Becomes Mature
- Picture the future: emerging imaging modalities
- Diagnostic Value of Diffusion-Weighted Imaging in Simultaneous 18F-FDG PET/MR Imaging for Whole-Body Staging of Women with Pelvic Malignancies
- An Integrated Quad-Modality Molecular Imaging System for Small Animals
- Principles of PET/MR Imaging
- PET/MR Imaging: A Critical Appraisal
- Utilisation of combined 18F-FDG PET/CT scan for differential diagnosis between benign and malignant adrenal enlargement
- The history of cerebral PET scanning: From physiology to cutting-edge technology
- Introduction
- Performance Measurements of the Siemens mMR Integrated Whole-Body PET/MR Scanner
- Multimodality Assessment of Brain Tumors and Tumor Recurrence
- Whole-Body 18F-FDG PET/CT: The Need for a Standardized Field of View--A Referring-Physician Aid
- Switching on the Lights for Real-Time Multimodality Tumor Neuroimaging: The Integrated Positron-Emission Tomography/MR Imaging System
- PET/MRI: Paving the Way for the Next Generation of Clinical Multimodality Imaging Applications
- Nonrigid Versus Rigid Registration of Thoracic 18F-FDG PET and CT in Patients with Lung Cancer: An Intraindividual Comparison of Different Breathing Maneuvers
- 18F-FDG PET/CT for Image-Guided and Intensity-Modulated Radiotherapy
- List Mode-Driven Cardiac and Respiratory Gating in PET
- Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration
- A Prospective Evaluation of 18F-FDG and 11C-Acetate PET/CT for Detection of Primary and Metastatic Hepatocellular Carcinoma
- Combined Assessment of Metabolic and Volumetric Changes for Assessment of Tumor Response in Patients with Soft-Tissue Sarcomas
- PET/MRI Dual-Modality Tumor Imaging Using Arginine-Glycine-Aspartic (RGD)-Conjugated Radiolabeled Iron Oxide Nanoparticles
- Multimodality Molecular Imaging of Tumor Angiogenesis
- Latest Advances in Molecular Imaging Instrumentation
- Dual-Modality Imaging: Combining Anatomy and Function
- PET Image Denoising Using a Synergistic Multiresolution Analysis of Structural (MRI/CT) and Functional Datasets
- VP-PET: A New Imaging Modality?
- Virtual-Pinhole PET
- Is There a Role for Positron Emission Tomography in Breast Cancer Staging?
- A Comparison of the Diagnostic Accuracy of 18F-FDG PET and CT in the Characterization of Solitary Pulmonary Nodules
- Application of PET/CT in the Development of Novel Anticancer Drugs
- 18F-FDG PET/CT in Evaluating Non-CNS Pediatric Malignancies
- Absolute Quantification of Myocardial Blood Flow with 13N-Ammonia and 3-Dimensional PET
- Diagnostic and Prognostic Value of 18F-FDG PET/CT for Patients with Suspected Recurrence from Squamous Cell Carcinoma of the Esophagus
- FDG-PET/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy
- Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer
- Introduction
- Improvements in Cancer Staging with PET/CT: Literature-Based Evidence as of September 2006
- Early Detection of Cancer Recurrence: 18F-FDG PET/CT Can Make a Difference in Diagnosis and Patient Care
- Monitoring Cancer Treatment with PET/CT: Does It Make a Difference?
- The 2006 Henry N. Wagner Lecture: Of Mice and Men (and Positrons)--Advances in PET Imaging Technology
- PET/CT in Lymphoma: Prospective Study of Enhanced Full-Dose PET/CT Versus Unenhanced Low-Dose PET/CT
- 18F-FDG PET/CT of Thymic Epithelial Tumors: Usefulness for Distinguishing and Staging Tumor Subgroups
- The Role of PET in Lymphoma
- Positron Emission Tomography As an Imaging Biomarker
- New Technologies and Directed Agents for Applications of Cancer Imaging
- PET/CT detects abdominal wall and port site metastases of colorectal carcinoma.
- SPECT-Guided CT for Evaluating Foci of Increased Bone Metabolism Classified as Indeterminate on SPECT in Cancer Patients
- Role of Nuclear Medicine in the Management of Cutaneous Malignant Melanoma
- Procedure Guideline for Tumor Imaging with 18F-FDG PET/CT 1.0
- Performance Test of an LSO-APD Detector in a 7-T MRI Scanner for Simultaneous PET/MRI
- Diagnostic Performance of Whole Body Dual Modality 18F-FDG PET/CT Imaging for N- and M-Staging of Malignant Melanoma: Experience With 250 Consecutive Patients
- Optimized Contrast-Enhanced CT Protocols for Diagnostic Whole-Body 18F-FDG PET/CT: Technical Aspects of Single-Phase Versus Multiphase CT Imaging
- Standard PET/CT of the Chest During Shallow Breathing Is Inadequate for Comprehensive Staging of Lung Cancer
- Whole-Body 18F-FDG PET/CT in the Presence of Truncation Artifacts
- Whole body positron emission tomography/computed tomography (PET/CT) tumour staging with integrated PET/CT colonography: technical feasibility and first experiences in patients with colorectal cancer
- PET/CT imaging: detection of choroidal melanoma
- Attenuation Correction of PET Images with Respiration-Averaged CT Images in PET/CT
- PET/CT Imaging Artifacts
- Concurrent PET/CT with an Integrated Imaging System: Intersociety Dialogue from the Joint Working Group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance
- Detection of Klatskin's Tumor in Extrahepatic Bile Duct Strictures Using Delayed 18F-FDG PET/CT: Preliminary Results for 22 Patient Studies
- Detection of Unexpected Additional Primary Malignancies with PET/CT
- Optimizing Imaging Protocols for Overweight and Obese Patients: A Lutetium Orthosilicate PET/CT Study
- On the Use of Positioning Aids to Reduce Misregistration in the Head and Neck in Whole-Body PET/CT Studies
- Do Implanted Pacemaker Leads and ICD Leads Cause Metal-Related Artifact in Cardiac PET/CT?
- Optimized Intravenous Contrast Administration for Diagnostic Whole-Body 18F-FDG PET/CT
- Molecular Imaging of Antiangiogenic Agents
- Application of Intravenous Contrast in PET/CT: Does It Really Introduce Significant Attenuation Correction Error?
- Is 18F-FDG PET/CT Useful for Imaging and Management of Patients with Suspected Occult Recurrence of Cancer?
- X-Ray Imaging Physics for Nuclear Medicine Technologists. Part 1: Basic Principles of X-Ray Production
- Impact of Patient Weight and Emission Scan Duration on PET/CT Image Quality and Lesion Detectability
- A Lesion Detection Observer Study Comparing 2-Dimensional Versus Fully 3-Dimensional Whole-Body PET Imaging Protocols
- Comparison of PET, CT, and Dual-Modality PET/CT Imaging for Monitoring of Imatinib (STI571) Therapy in Patients with Gastrointestinal Stromal Tumors
- Cardiac Pacemakers and Central Venous Lines Can Induce Focal Artifacts on CT-Corrected PET Images
- Software Approach to Merging Molecular with Anatomic Information
- PET/CT Imaging: Facts, Opinions, Hopes, and Questions
- Acquisition Protocol Considerations for Combined PET/CT Imaging
- To Enhance or Not to Enhance? 18F-FDG and CT Contrast Agents in Dual-Modality 18F-FDG PET/CT
- PET/CT Today and Tomorrow
- Clinical Usefulness of Fusion of 131I SPECT and CT Images in Patients with Differentiated Thyroid Carcinoma
- Positron emission tomographic imaging of angiogenesis and vascular function
- Clinical Performance of PET/CT in Evaluation of Cancer: Additional Value for Diagnostic Imaging and Patient Management